ECMO for Refractory Septic Shock Prof. Alain Combes
|
|
|
- Gervase Harris
- 6 years ago
- Views:
Transcription
1 ECMO for Refractory Septic Shock Prof. Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre et Marie Curie, Paris 6 alain.combes@psl.aphp.fr
2 Conflict of Interest Principal Investigator: EOLIA trial VV ECMO in ARDS NCT Sponsored by MAQUET, Getinge Group Received honoraria from MAQUET, Baxter, ALung
3 Reversible myocardial dysfunction during sepsis Parker MM, Ann Intern Med 1984
4 Reversible myocardial dysfunction during sepsis Parrillo et al., JCI 1985
5 Reversible myocardial dysfunction during sepsis Circulating Myocardial Depressant Substance (MDS) Endotoxine? TNF-α? IL-1β? IL-6? NO? Parrillo et al., JCI 1985
6 Reversible myocardial dysfunction during sepsis Half of the nonsurvivors developed a decreasing cardiac index, with no change in heart rate or ejection fraction, (..) and become those nonsurvivors who die of a cardiogenic shock-like state. Parker MM, J Crit Care 1989
7 Continuum in several consecutive phases Early phase: Low-flow state related to hypovolemia Volume expansion increases cardiac output and improves patient s perfusion Second phase: Hyperdynamic state High cardiac output Low systemic vascular resistance Third phase: Decreased cardiac output Increased systemic vascular resistance Progressive metabolic acidosis
8 Understanding cardiac failure in sepsis Antoine Vieillard-Baron M. Cecconi ICM, 2014
9 Reversible myocardial dysfunction during sepsis Role of catecholamines? Reversible Left Ventricular Dysfunction Takotsubo Cardiomyopathy Related to Catecholamine Cardiotoxicity Akashi, Journal of Electrocardiology 2002
10 ECMO & Sepsis Pediatric data
11 ECMO & Sepsis Pediatric data Publication Beca, Pediatrics 94 Goldman, Lancet 1997 Luyt, Acta Paediatr 2004 MacLaren, Pediatr Crit Care Med 2007 MacLaren, Pediatr Crit Care Med 2011 MacLaren, Anaesth Intensive Care 2004 Vohra, Ann Thorac Surg 2009 Firstenberg, Am Surg 2010 Age Nb of patients, context ECMO type Pre-ECMO myocardial dysfunction Survival, n (%) ECMO duration, median Child 9, septic shock PVA? 5 (55%) 5,7 (2,4-9,6) Child 12, meningococcemia 10 PVA, 2 VV? 8 (66%) 3,2 (0,8-10,9) Child 6, meningococcemia PVA? 1 (17%) 4,3 (3-7,2)? Child 45, septic shock PVA (76%) & central (24%)? 21 (47%) 3,5 (1,3-5,6) ICU stay median 32 (17-38) 12 (7-35) 9 (3,5-14) Child 23, septic shock Central VA? 17 (74)% 3,9 (1,8-4,9) 9,7 (7,8-15,7) Adult 1, bacteriemia MSSA PVA + 1/ Adult Adult 1, septic shock after cardiac surgery 2, necrotizing dermatitis PVA + 1/ PVA + 2/2 4 (3-5) 51 (47-55), hospital stay
12 ECMO & Sepsis Pediatric data Publication Beca, Pediatrics 94 Goldman, Lancet 1997 Luyt, Acta Paediatr 2004 MacLaren, Pediatr Crit Care Med 2007 MacLaren, Pediatr Crit Care Med 2011 MacLaren, Anaesth Intensive Care 2004 Vohra, Ann Thorac Surg 2009 Firstenberg, Am Surg 2010 Age Nb of patients, context ECMO type Pre-ECMO myocardial dysfunction Survival, n (%) ECMO duration, median Child 9, septic shock PVA? 5 (55%) 5,7 (2,4-9,6) Child 12, meningococcemia 10 PVA, 2 VV? 8 (66%) 3,2 (0,8-10,9) Child 6, meningococcemia PVA? 1 (17%) 4,3 (3-7,2)? Child 45, septic shock PVA (76%) & central (24%)? 21 (47%) 3,5 (1,3-5,6) ICU stay median 32 (17-38) 12 (7-35) 9 (3,5-14) Child 23, septic shock Central VA? 17 (74)% 3,9 (1,8-4,9) 9,7 (7,8-15,7) Adult 1, bacteriemia MSSA PVA + 1/ Adult Adult 1, septic shock after cardiac surgery 2, necrotizing dermatitis PVA + 1/ PVA + 2/2 4 (3-5) 51 (47-55), hospital stay
13 McLaren, Ped Crit Care Med pts (17 M/ 28 F) Mean age 2,5-12 Refractory septic shock BC+91%, MOF>3 All on catecholamine Dopa 12 μg/kg/min (5-20), n=32 Dobu 17,3μg/kg/min (10-25), n=14 Norepi 1 μg/kg/min (0,02-4), n=33 Epi 1,85 μg/kg/min (0,05-10), n=33 18 (40%) CPR-ECMO
14 McLaren, Ped Crit Care Med 07 ECMO support 34 (76%) peripheral VA-ECMO 22 (6,5-38) hours after shock onset Durations, days ECMO: 3.5(1-5) ICU: 9(3.5-14) Hospital 16(3.6-36) 21/45 (47%) SURVIVAL
15 McLaren, Ped Crit Care Med 07 Long-term Outcomes 5 years (0.3-14) No death Disability 13 (62%) no disability 5 (24%) minor disability 3 (14%) moderate None had severe disability
16
17 Guidelines Crit Care Med 09
18 Guidelines Crit Care Med 09
19 ECMO and Septic Shock Data in Adult Patients
20
21
22
23 c c c
24
25 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Venoarterial ECMO n=222 Venoarterial ECMO n=222 Bréchot et al, Crit Care Med, 2013 Refractory septic shock n = 14 Refractory septic shock
26
27 14 septic shock patients 7 M/ 7 F, 45 years (28-66) 6 Immunocompromised 12 CA, 2 nosocomial 11/14 severe bacterial pneumonia 8/14 ECMO via Mobile team
28
29 6/14 Streptococcus pneumonia 2 Legionella pneumophila 2 Staphylococcus aureus
30 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, 2013 Patients n=14 Value Age, yr, median (range) 45 (28 66) ECMO implantation by UMAC, n 8 Shock onset-to-ecmo interval, hrs, median 24 (3 108) Femoral ECMO, n 14 Left ventricular ejection fraction (%), median 16 (10 30) Catecholamine dose, g/kg/min, median Dobutamine, n= (6 30) Norepinephrine, n= ( ) Epinephrine, n= ( ) Pre-ECMO mean arterial pressure, mmhg, median 72 (53-105) Pre-ECMO central venous pressure, mmhg, median 18 (10-35) Pre-ECMO cardiac index, L/min/m 2, median 1.3 ( ) Pre-ECMO systemic resistance vascular index, 3162 ( ) SOFA score, median 18 (8 21) ph, median 7.16 ( ) Blood lactate, median 9 (2 17) N-Terminal pro-brain natriuretic peptide, pg/ml 29,788 (1,843 35,000)
31 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, 2013 Patients n=14 Value Age, yr, median (range) 45 (28 66) ECMO implantation by UMAC, n 8 Shock onset-to-ecmo interval, Very hrs, median specific 24 (3 108) Femoral ECMO, n 14 Left ventricular ejection fraction (%), median 16 (10 30) hemodynamic profile Catecholamine dose, g/kg/min, median Dobutamine, n= (6 30) Norepinephrine, n= ( ) Low LVEF Epinephrine, n= ( ) Pre-ECMO mean arterial pressure, mmhg, median 72 (53-105) Pre-ECMO central venous pressure, mmhg, median 18 (10-35) Low Pre-ECMO cardiac index, L/min/m 2 CI, median 1.3 ( ) Pre-ECMO systemic resistance vascular index, 3162 ( ) SOFA score, median 18 (8 21) High vascular resistance ph, median 7.16 ( ) Blood lactate, median 9 (2 17) N-Terminal pro-brain natriuretic peptide, pg/ml 29,788 (1,843 35,000)
32 Peripheral VA-ECMO cannulation
33 Peripheral cannulation
34 The ECMO circuit: Centrifugal pump Electrical Centrifugal pump 0->4000 RPM Can deliver flows up to 8 L/min Very reliable Up to 21 days
35 The ECMO circuit: Central Unit Controller Flow alarms
36 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, 2013 Severe ARDS in addition to refractory cardiogenic shock
37 The ECMO circuit: Membrane Oxygenator Hollow fiber membrane oxygenator Polymethylpentene Heparin-coated High performance CO2 elimination Blood oxygenation Low pressure drop Long duration d
38 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, 2013 Venoarterial ECMO n=222 Refractory septic shock n = 14 2 Deaths under ECMO 2 Deaths in ICU 10 Long-term survivors
39 The case of a 54 yrs old patient with severe CA pneumonia Had VA-ECMO for septic shock and evolution towards cardiogenic shock
40 At ECMO initiation
41 On Day one
42 On day 5
43 On day 7
44 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, 2013 *** *** Time to LV recovery <5 days
45 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, 2013 *** *** Five patients had their VA-ECMO switched to VV-ECMO for 5 days (range, 3 21) because of persistent severe respiratory failure
46 Peripheral VA ECMO is not indicated for ARF because Flow competition in the aorta Heart vs. ECMO pump If pulmonary function is impaired The Harlequin syndrome Blue head : deoxygenated blood directed to the upper part of the body Red legs : hyperoxygenated blood in the lower part of the body Not possible to rest the lungs Vt, Pplat and FiO2 cannot be reduced
47 Long-term HRQL
48 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, 2013 A A * * * * * * * * * * * * * * * * * * * * B * * B *
49 Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock Bréchot et al, Crit Care Med, A * * * * * * * * * * 10 0 PCS MCS
50 Conclusion Cardiogenic shock Rare but life-threatening complication of severe septic shock Low CI, Low LVEF, High Catecho, High SVR VA-ECMO to rescue these dying patients 70% survival if treated early Rapid recovery of LV function Severe ARDS may require switch to VV-ECMO Good long-term HRQL Network of hospitals, Mobile ECMO team+++
51
NE refractoriness: From Definition To Treatment... Prof. Alain Combes
NE refractoriness: From Definition To Treatment... Prof. Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre
Which mechanical assistance for cardiogenic shock?
Which mechanical assistance for cardiogenic shock? Alain Combes, MD, PhD, Hôpital Pitié-Salpêtrière, AP-HP Inserm UMRS 1166, ican, Institute of Cardiometabolism and Nutrition Pierre et Marie Curie Sorbonne
IABP to prevent pulmonary edema under VA-ECMO
IABP to prevent pulmonary edema under VA-ECMO Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre et Marie Curie,
ECLS. The Basics. Jeannine Hermens Intensive Care Center UMC Utrecht
ECLS The Basics Jeannine Hermens Intensive Care Center UMC Utrecht Conflict of interest None Terminology ECMO - ExtraCorporeal Membrane Oxygenation ECLS - ExtraCorporeal Life Support PLS - Veno-venous
ECMO/ECCO 2 R in Acute Respiratory Failure
ECMO/ECCO 2 R in Acute Respiratory Failure Alain Combes, MD, PhD, Hôpital Pitié-Salpêtrière, AP-HP Inserm UMRS 1166, ican, Institute of Cardiometabolism and Nutrition Sorbonne Pierre et Marie Curie University,
ICU Volume 14 - Issue 1 - Spring Matrix
ICU Volume 14 - Issue 1 - Spring 2014 - Matrix The ECMO Retrieval Team Authors Alain Combes, MD Medical-Surgical Intensive Care Unit ican, Institute of Cardiometabolism and Nutrition Hôpital de la Pitié
Experience with Low Flow ECCO2R device on a CRRT platform : CO2 removal
Experience with Low Flow ECCO2R device on a CRRT platform : CO2 removal Alain Combes, MD, PhD, Hôpital Pitié-Salpêtrière, AP-HP Inserm UMRS 1166, ican, Institute of Cardiometabolism and Nutrition Pierre
AllinaHealthSystem 1
: Definition End-organ hypoperfusion secondary to cardiac failure Venoarterial ECMO: Patient Selection Michael A. Samara, MD FACC Advanced Heart Failure, Cardiac Transplant & Mechanical Circulatory Support
Severe Myocarditis: A 2012 update
Severe Myocarditis: A 2012 update Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre et Marie Curie, Paris 6
UNUSUAL INDICATIONS FOR ECMO
DISCLOSURE UNUSUAL INDICATIONS FOR ECMO DAVE WILLIAMS D.O. INTENSIVIST AT ABBOTT NORTHWESTERN HOSPITAL There are no conflicts of interest or relevant financial interests in making this presentation and
ECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest
ECMO: a breakthrough in care for respiratory failure? PD Dr. Thomas Müller Regensburg no conflict of interest 1 Overview Mortality of severe ARDS Indication for ECMO PaO 2 /FiO 2 Efficiency of ECMO: gas
Veno-Venous ECMO Support. Chris Cropsey, MD Sept. 21, 2015
Veno-Venous ECMO Support Chris Cropsey, MD Sept. 21, 2015 Objectives List indications and contraindications for ECMO Describe hemodynamics and oxygenation on ECMO Discuss evidence for ECMO outcomes Identify
To ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW
To ECMO Or Not To ECMO Challenges of venous arterial ECMO Dr Emily Granger St Vincent s Hospital Darlinghurst NSW The Start: 1972 St Vincent s Hospital The Turning Point ECMO program restarted in 2004
In the setting of liver failure & transplantation?
ECMO: In the setting of liver failure & transplantation? Dr. Robert Loveridge MA LL.M MRCP FRCA FFICM Consultant in adult & liver intensive care medicine King s College Hospital NHS Foundation Trust What
ECMO Primer A View to the Future
ECMO Primer A View to the Future Todd J. Kilbaugh Assistant Professor of Anesthesiology, Critical Care Medicine, and Pediatrics Director of The ECMO Center at the Children s Hospital of Philadelphia Disclosures
ECMO BASICS CHLOE STEINSHOUER, MD PULMONARY AND SLEEP CONSULTANTS OF KANSAS
ECMO BASICS CHLOE STEINSHOUER, MD PULMONARY AND SLEEP CONSULTANTS OF KANSAS DISCLOSURES No financial disclosures or conflicts of interest OBJECTIVES Define ECMO/ECLS and be able to identify the main types
Echo assessment of patients with an ECMO device
Echo assessment of patients with an ECMO device Evangelos Leontiadis Cardiologist 1st Cardiology Dept. Onassis Cardiac Surgery Center Athens, Greece Gibbon HLM 1953 Goldstein DJ et al, NEJM 1998; 339:1522
Case scenario V AV ECMO. Dr Pranay Oza
Case scenario V AV ECMO Dr Pranay Oza Case Summary 53 y/m, k/c/o MVP with myxomatous mitral valve with severe Mitral regurgitation underwent Mitral valve replacement with mini thoracotomy Pump time nearly
Management of Acute Shock and Right Ventricular Failure
Management of Acute Shock and Right Ventricular Failure Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic NONE Disclosures CARDIOGENIC SHOCK
Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017
Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017 Pascal Vranckx MD, PhD. Medical director Cardiac Critical Care Services Hartcentrum Hasselt Belgium Disclosure
Adult Extracorporeal Life Support (ECLS)
Adult Extracorporeal Life Support (ECLS) Steven Scott, M.D., F.A.C.S. Piedmont Heart Institute Cardiothoracic Surgery Disclosures None ECMO = ECLS A technique of life support that involves a continuous
ECMO for cardiac arrest patients: Update 2017
ECMO for cardiac arrest patients: Update 2017 Lim Swee Han MBBS (NUS), FRCS Ed (A&E), FRCP (Edin), FAMS Senior Consultant, Department of Emergency Medicine, Singapore General Hospital Adjunct Associate
BASIC CRITICAL CARE OF THE PATIENT. Hannelisa Callisen PA C February 2017
BASIC CRITICAL CARE OF THE PATIENT Hannelisa Callisen PA C February 2017 Disclosures Industry: None ECMO is off label Objectives ECMO initiation selection, cannulation Physiology : Review of DO2 on ECMO
Pheochromocytoma Crisis Presenting as Fulminant Cardiopulmonary Failure: A Case Report
170 Pheochromocytoma Crisis Presenting as Fulminant Cardiopulmonary Failure: A Case Report Chun-Wen Chiu 1, Cheng-Hsiung Chen 2 Fulminant cardiopulmonary failure in a patient with pheochromocytoma is a
10/16/2017. Review the indications for ECMO in patients with. Respiratory failure Cardiac failure Cardiorespiratory failure
Review the indications for ECMO in patients with Respiratory failure Cardiac failure Cardiorespiratory failure 1 Extracorporeal membrane lung and/or cardiac support. A support therapy, in no way definitive.
ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan
ECMO as a bridge to durable LVAD therapy Jonathan Haft, MD Department of Cardiac Surgery University of Michigan Systolic Heart Failure Prevalence 4.8 million U.S. 287,000 deaths per year $39 billion spent
ECCO 2 Removal The Perfusionists Perspective
ECCO 2 Removal The Perfusionists Perspective BelSECT Education evening 2016-06-15 D. Hella, Th. Amand, J-N Koch Definition ECCO 2 Removal: Process by which an extracorporeal circuit is used for removing
Lesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care
Lesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care Disclosures I have no financial disclosures. The use of certain devises for providing long-term cardiopulmonary support is investigational.
Effects of mechanical ventilation on organ function. Masterclass ICU nurses
Effects of mechanical ventilation on organ function Masterclass ICU nurses Case Male, 60 - No PMH - L 1.74 m and W 85 kg Pneumococcal pneumonia Stable hemodynamics - No AKI MV in prone position (PEEP 16
Outcomes From Severe ARDS Managed Without ECMO. Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016
Outcomes From Severe ARDS Managed Without ECMO Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016 Severe ARDS Berlin Definition 2012 P:F ratio 100 mm Hg Prevalence:
Online data supplement
Online data supplement Predicting Survival after Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Failure: the Respiratory ECMO Survival Prediction (RESP)-Score. Matthieu Schmidt 1,2, Michael
Cardiovascular Institute
Allegheny Health Network Cardiovascular Institute Extracorporeal Membrane Oxygenation (ECMO) Program Our patient survival rate is higher than the national average. ECMO experts. Multidisciplinary team.
Disclosures. Objectives 10/11/17. Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock. I have no disclosures to report
Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock Christopher K. Gordon MSN, ACNP-BC Disclosures I have no disclosures to report 1. Pathophysiology 2. Epidemiology 3. Assessment
Sepsis and septic shock Practical hemodynamic consequences. Intensive Care Training Program Radboud University Medical Centre Nijmegen
Sepsis and septic shock Practical hemodynamic consequences Intensive Care Training Program Radboud University Medical Centre Nijmegen Septic cardiomyopathy Present in > 50% and often masked by low vascular
Acute heart failure, beyond conventional treatment: persisting low output
Acute heart failure, beyond conventional treatment: persisting low output Alexandre Mebazaa, FESC Hôpital Lariboisière, Université Paris 7 U942 Inserm Conflict of Interest Lecture fee: Orion No other conflicts
ECMO: the wave of the future??
ECMO: the wave of the future?? 15th May 2018 P. Andrew Stephens, MD, FACEP LTC, MC, FS, DMO 19th Special Forces Group (Airborne) Surgeon Background Armored Cav Board EM Critical Care Neurocritical Care
Research in ECMO: A revolution is coming
Research in ECMO: A revolution is coming Daniel Brodie Critical Care Canada Forum Toronto, Ontario October 27 th, 2015 Research in ECMO: A revolution is coming??? Daniel Brodie Critical Care Canada Forum
SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital
SHOCK Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital 1 Definition Shock is an acute, complex state of circulatory dysfunction
Troubleshooting Adult ECMO
The Journal of ExtraCorporeal Technology Troubleshooting Adult ECMO David Sidebotham, FANZCA Departments of Anaesthesia and Intensive Care, Auckland City Hospital, Auckland, New Zealand Presented at Perfusion
Extracorporeal membrane oxygenators (ECMO) provide
Case Report Interhospital Transport of the ECMO Patients in Bangkok Hospital Abstract An extracorporeal membrane oxygenator (ECMO) is used to support the heart and lungs in patients with severe cardiogenic
Vasopressors for shock
Vasopressors for shock Background Reviews and Observational Studies Holler 2015. Nontraumatic Hypotension and Shock in the Emergency Department and Prehospital Setting Prevalence, Etiology and Mortality:
Cardiovascular Management of Septic Shock
Cardiovascular Management of Septic Shock R. Phillip Dellinger, MD Professor of Medicine Robert Wood Johnson Medical School/UMDNJ Director, Critical Care Medicine and Med/Surg ICU Cooper University Hospital
Special features of cardiogenic failure in sepsis. Krisztina Madách
Special features of cardiogenic failure in sepsis Krisztina Madách The problem in focus Incidence of sepsis is increasing Severe sepsis and septic shock are leading cause of death in ICU Septic patients
Extracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 01/01/2017 Section: Other/Miscellaneous
Irreversible shock can defined as last phase of shock where despite correcting the initial insult leading to shock and restoring circulation there is
R. Siebert Irreversible shock can defined as last phase of shock where despite correcting the initial insult leading to shock and restoring circulation there is a progressive decline in blood pressure
towards early goal directed therapy
Paediatric Septic Shock- towards early goal directed therapy Elliot Long Paediatric Acute Care 2011 Conference Outline Emergency Department Rivers Protocol (EGDT) ACCM Sepsis Protocol Evidence Barriers
Accepted Manuscript. Extracorporeal Membrane Oxygenation for Septic Shock: Heroic Futility? Francis D. Pagani, MD PhD
Accepted Manuscript Extracorporeal Membrane Oxygenation for Septic Shock: Heroic Futility? Francis D. Pagani, MD PhD PII: S0022-5223(18)31214-5 DOI: 10.1016/j.jtcvs.2018.04.076 Reference: YMTC 12949 To
FOCUS CONFERENCE 2018
FOCUS CONFERENCE 2018 Current Practice in Pediatric and Neonatal Extracorporeal Life Support Daniel W. Chipman, RRT Assistant Director of Respiratory Care Massachusetts General Hospital Boston, Massachusetts
Sepsis and septic shock
Sepsis and septic shock Practical hemodynamic consequences Intensive Care Training Program Radboud University Medical Centre Nijmegen Septic cardiomyopathy Present in > 50% and often masked by low vascular
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
ECMO and VAD implantation
1 Udine ECMO Workshop ECMO and VAD implantation Prof. Tomaso Bottio Division of Cardiac Surgery (Director Prof. Gino gerosa) ECMO Extracorporeal membrane oxygena1on (ECMO) is a rescue therapy to support
ECLS as Bridge to Transplant
ECLS as Bridge to Transplant Marcelo Cypel MD, MSc Assistant Professor of Surgery Division of Thoracic Surgery Toronto General Hospital University of Toronto Application of ECLS Bridge to lung recovery
Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)
Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO) Michael A. Gibson, MD Assistant Professor of Medicine University of California, Irvine Division of Cardiology
Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure
Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure Introduction This pediatric respiratory failure guideline is a supplement to ELSO s General Guidelines for all
Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50
Case 1 65 year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50 Case 1 65 year old female nursing home resident with
ECMO CPR. Ravi R. Thiagarajan MBBS, MPH. Cardiac Intensive Care Unit
ECMO CPR Ravi R. Thiagarajan MBBS, MPH Staff Intensivist Cardiac Intensive Care Unit Children s Hospital Boston PCICS 2008, Miami, FL No disclosures Disclosures Outline Outcomes for Pediatric in-hospital
Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist
Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic
Cardiogenic Shock in Acute MI
Cardiogenic Shock in Acute MI Mark Sheldon, MD UNMH Interventional Cardiology Objectives Overview Treatment Definition Shock profiles Causes Medical Mechanical Illustrative case Questions? Revascularization
Innovative ECMO Configurations in Adults
Innovative ECMO Configurations in Adults Practice at a Single Center with Platinum Level ELSO Award for Excellence in Life Support Monika Tukacs, BSN, RN, CCRN Columbia University Irving Medical Center,
Use of Blood Lactate Measurements in the Critical Care Setting
Use of Blood Lactate Measurements in the Critical Care Setting John G Toffaletti, PhD Director of Blood Gas and Clinical Pediatric Labs Professor of Pathology Duke University Medical Center Chief, VAMC
DECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Cardiogenic Shock Mechanical Support Eulàlia Roig FESC Heart Failure and HT Unit Hospital Sant Pau - UAB Barcelona. Spain No conflics of interest Mechanical Circulatory
Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview Mechanical Ventilation of Sepsis-Induced ALI/ARDS ARDSnet Mechanical Ventilation Protocol Results: Mortality
Extracorporeal Life Support (ECLS) as a Bridge to Decision in Lung Transplantation
Extracorporeal Life Support (ECLS) as a Bridge to Decision in Lung Transplantation Gabriel Loor, MD Baylor St. Lukes Medical Center Surgical Director Lung Transplantation Co-chief Section of Adult Cardiac
Extracorporeal Membrane Oxygenation in Cardiac Intensive Care Unit
10 Review Article THIEME Extracorporeal Membrane Oxygenation in Cardiac Intensive Care Unit Venkat Goyal 1 Pranay Oza 1 1 Riddhi Vinayak Critical Care and Cardiac Centre, Mumbai, Maharashtra, India J Card
Extracorporeal membrane oxygenation resuscitation in adult patients with refractory septic shock
ACQUIRED CARDIOVASCULAR DISEASE Extracorporeal membrane oxygenation resuscitation in adult patients with refractory septic shock Chun-Ta Huang, MD, a,b Yi-Ju Tsai, PhD, c Pi-Ru Tsai, RN, d and Wen-Je Ko,
Device Therapy for Heart Failure
Device Therapy for Heart Failure Dr. Shelley Zieroth FRCPC Assistant Professor, Cardiology, University of Manitoba Director of Cardiac Transplant and Heart Failure Clinics St Boniface General Hospital,
Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children?
Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children? J. Lemson Anesthesiologist/(pediatric)intensivist Case; Girl 2 years, 12 kg, severe meningococcal septic
ECMO and refractory Hypoxemia
ECMO and refractory Hypoxemia Dr. Vinay Dhingra MD FRCPC Clinical Associate Professor of Medicine Clinical Lead Critical Care BCPSQC Medical Director Quality VGH Disclosures ARDS Lancet 1967; 2:319-323
Extracorporeal support in acute respiratory failure. Dr Anthony Bastin Consultant in critical care Royal Brompton Hospital, London
Extracorporeal support in acute respiratory failure Dr Anthony Bastin Consultant in critical care Royal Brompton Hospital, London Objectives By the end of this session, you will be able to: Describe different
ECMO vs. CPB for Intraoperative Support: How do you Choose?
ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon
Management of refractory ARDS. Saurabh maji
Management of refractory ARDS Saurabh maji Refractory hypoxemia as PaO2/FIO2 is less than 100 mm Hg, inability to keep plateau pressure below 30 cm H2O despite a VT of 4 ml/kg development of barotrauma
8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes
8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference 2017 OSPEDALE Dubai: 19-21 October 2017 Acute Coronary Syndromes Antonio Colombo Centro Cuore Columbus and S. Raffaele
(Peripheral) Temperature and microcirculation
(Peripheral) Temperature and microcirculation Prof. Jan Bakker MD, PhD Chair dept Intensive Care Adults jan.bakker@erasmusmc.nl www.intensivecare.me Intensive Care Med (2005) 31:1316 1326 DOI 10.1007/s00134-005-2790-2
Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada
Vasopressors in Septic Shock Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada Echocardiogram: EF=25% 57 y.o. female, pneumonia, shock Echocardiogram: EF=25% 57 y.o.
Making vasopressors safer
Making vasopressors safer Requirements for safe vaspressor use In an ideal world 1. Knowledge of what constitutes optimal vasopressor dosing 2. A culture of cautiousness regarding vasopressors What do
Hemodynamic monitoring beyond cardiac output
Hemodynamic monitoring beyond cardiac output Prof Xavier MONNET Medical Intensive Care Unit Bicêtre Hospital Assistance publique Hôpitaux de Paris FRANCE Conflicts of interest Lilly GlaxoSmithKline Pulsion
Mechanics of Cath Lab Support Devices
Mechanics of Cath Lab Support Devices Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, Florida DISCLOSURE Presenter:
NUTRITION SUPPORT DURING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) IN CRITICALLY ILL ADULT PATIENTS. Haley Murrell, March 19, 2015
NUTRITION SUPPORT DURING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) IN CRITICALLY ILL ADULT PATIENTS Haley Murrell, March 19, 2015 Objectives Provide an overview of Extracorporeal Membrane Oxygenation
Sepsis Combine experience and Evidence. Eran Segal, MD Director General ICU, Sheba Medical Center, Israel
Sepsis Combine experience and Evidence Eran Segal, MD Director General ICU, Sheba Medical Center, Israel The Science of Sepsis A complex and diverse clinical entity Outcome is affected by: Infecting organism
CARDIOGENIC SHOCK. Antonio Pesenti. Università degli Studi di Milano Bicocca Azienda Ospedaliera San Gerardo Monza (MI)
CARDIOGENIC SHOCK Antonio Pesenti Università degli Studi di Milano Bicocca Azienda Ospedaliera San Gerardo Monza (MI) Primary myocardial dysfunction resulting in the inability of the heart to mantain an
Acute Respiratory Distress Syndrome (ARDS) An Update
Acute Respiratory Distress Syndrome (ARDS) An Update Prof. A.S.M. Areef Ahsan FCPS(Medicine) MD(Critical Care Medicine) MD ( Chest) Head, Dept. of Critical Care Medicine BIRDEM General Hospital INTRODUCTION
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive
Bridging With Percutaneous Devices: Tandem Heart and Impella
Bridging With Percutaneous Devices: Tandem Heart and Impella DAVID A. BARAN, MD, FACC, FSCAI SYSTEM DIRECTOR, ADVANCED HEART FAILURE, TX AND MCS SENTARA HEART HOSPITAL NORFOLK, VA PROFESSOR OF MEDICINE
ECMO & Renal Failure Epidemeology Renal failure & effect on out come
ECMO Induced Renal Issues Transient renal dysfunction Improvement in renal function ECMO & Renal Failure Epidemeology Renal failure & effect on out come With or Without RRT Renal replacement Therapy Utilizes
Epidemiology of Heart Failure in Adults
Cardiac Critical Care : Focused on IABP & PCPS Epidemiology of Heart Failure in Adults Prevalence Incidence Mortality 2004 Hospital Cost 2007 2004 Age 20+ (New Cases) All Ages Discharges Age 35+ 2004 All
Extracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/01/2014 Section: Other/Miscellaneous
Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support
Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support Mahir Elder, MD, FACC,SCAI Medical Direct of PERT program Medical Director of Endovascular medicine Clinical Professor
Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring
Introduction Invasive Hemodynamic Monitoring Audis Bethea, Pharm.D. Assistant Professor Therapeutics IV January 21, 2004 Hemodynamic monitoring is necessary to assess and manage shock Information obtained
Mechanics of Cath Lab Support Devices
Mechanics of Cath Lab Support Devices Issam D. Moussa, MD Chief Medical Officer First Coast Cardiovascular Institute, Jacksonville, FL Professor of Medicine, UCF, Orlando, FL None DISCLOSURE Percutaneous
Acute heart failure: ECMO Cardiology & Vascular Medicine 2012
Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist 14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart
ECLS Bridge to Lung Transplantation Optimizing and Ambulating the Recipient
ECLS Bridge to Lung Transplantation Optimizing and Ambulating the Recipient Shaf Keshavjee MD MSc FRCSC FACS Surgeon-in-Chief, University Health Network James Wallace McCutcheon Chair in Surgery Director,
ECMO for treatment of cardiotoxic intoxications
ECMO for treatment of cardiotoxic intoxications Bruno Mégarbane, MD, PhD Medical and Toxicological Critical Care Department Lariboisiere Hospital, INSERM UMRS-1144, Paris-Diderot University Paris France
Extracorporeal membrane oxygenation with multiple-organ failure: Can molecular adsorbent recirculating system therapy improve survival?
Thomas Jefferson University Jefferson Digital Commons Department of Surgery Faculty Papers Department of Surgery 1-1-2017 Extracorporeal membrane oxygenation with multiple-organ failure: Can molecular
Vasopressors in septic shock
Vasopressors in septic shock Prof. Jean-Louis TEBOUL Medical ICU Bicetre hospital University Paris-South France Questions 1- Why do we use vasopressors in septic shock? 2- Which first-line agent? 3- When
Goal-directed vs Flow-guidedresponsive
Goal-directed vs Flow-guidedresponsive therapy S Magder Department of Critical Care, McGill University Health Centre Flow-directed vs goal directed strategy for management of hemodynamics S Magder Curr
Acute Liver Failure: Supporting Other Organs
Acute Liver Failure: Supporting Other Organs Michael A. Gropper, MD, PhD Professor of Anesthesia and Physiology Director, Critical Care Medicine University of California San Francisco Acute Liver Failure
EARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer
EARLY GOAL DIRECTED THERAPY : Etat des lieux en 2017 Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles Past-President European
Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio
Biventricular Heart Failure Advanced Treatment Options at The Cleveland Clinic Jennifer A. Brown The Cleveland Clinic School of Perfusion Cleveland, Ohio I have no disclosures. Examine respiratory and
Early and Intermediate Results of Rescue Extracorporeal Membrane Oxygenation in Adult Cardiogenic Shock
Early and Intermediate Results of Rescue Extracorporeal Membrane Oxygenation in Adult Cardiogenic Shock Jiangang Wang, MD, Jie Han, MD, Yixin Jia, MD, Wen Zeng, MD, Jiahai Shi, MD, Xiaotong Hou, MD, and
Part 2 of park s Ventilator and ARDS slides for syllabus
Part 2 of park s Ventilator and ARDS slides for syllabus Early Neuromuscular Blockade Question 4 The early use of cis-atracurium in severe ARDS is: A. Contraindicated in patients with diabetes B. Associated